大行評級 | 大和:上調建設銀行(0939.HK)目標價至7.25港元 重申買入評級
格隆匯3月31日丨大和發表研究報告表示,將建行(0939.HK)目標價由6.7港元升至7.25港元;重申“買入”評級及行業首選之一。
報告指,預計建行2022年信貸業務前景良好,獨特的增長動力包括房屋租賃和金融科技應用。對於資產增長,建行並未給出具體指導,而是表示將爲實體經濟“加大支持力度”,保持貸款合理增長。資產質量方面,建行看好中國最新經濟指標 ,預計其資產質量和信貸成本將隨着不良貸款處理增加而趨於穩定。
該行指,對2022-23年撥備前利潤(PPOP)和淨利潤預測提升,主要受以下因素影響,包括短期淨息差壓力大但長期管理能力及信貸成本控制好於預期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.